Simulations Plus (SLP) Preliminary Revs. for FQ4 and FY2012
Tweet
Share
E-mailGet Alerts SLP Hot Sheet
Price: $18.46 --0%
Financial Fact:
Net basic earning per share (in Dollars per share): 0.11
Today's EPS Names:
OCCI, PMCB, BRID, More
Financial Fact:
Net basic earning per share (in Dollars per share): 0.11
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
Simulations Plus, Inc. (Nasdaq: SLP) released preliminary revenues for its fourth fiscal quarter of fiscal year 2012, ended August 31, 2012 (4QFY12), and for the entire fiscal year 2012 (FY12).
Preliminary revenues for the pharmaceutical software and services portion of the business increased to a new fourth quarter record of $1.640 million, compared to $1.427 million in 4QFY11.
Preliminary revenues for the pharmaceutical software and services portion of the business increased to a new fiscal year record of $9.449 million in FY12, compared to $8.739 million in FY11.
Preliminary revenues for the pharmaceutical software and services portion of the business increased to a new fourth quarter record of $1.640 million, compared to $1.427 million in 4QFY11.
Preliminary revenues for the pharmaceutical software and services portion of the business increased to a new fiscal year record of $9.449 million in FY12, compared to $8.739 million in FY11.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Webuy Global revenue nearly doubles in first half of 2026
- Zymeworks raises 2026 guidance after closing Theravance acquisition
- Kroger outlines AI strategy at GroceryShop 2026 conference
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
